Maria Stepanova

17.4k total citations · 9 hit papers
295 papers, 12.7k citations indexed

About

Maria Stepanova is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Maria Stepanova has authored 295 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Epidemiology, 191 papers in Hepatology and 35 papers in Surgery. Recurrent topics in Maria Stepanova's work include Liver Disease Diagnosis and Treatment (192 papers), Hepatitis C virus research (121 papers) and Liver Disease and Transplantation (87 papers). Maria Stepanova is often cited by papers focused on Liver Disease Diagnosis and Treatment (192 papers), Hepatitis C virus research (121 papers) and Liver Disease and Transplantation (87 papers). Maria Stepanova collaborates with scholars based in United States, Russia and United Kingdom. Maria Stepanova's co-authors include Zobair M. Younossi, Linda Henry, Youssef Younossi, Nila Rafiq, Sharon Hunt, Zachary Goodman, Manirath Srishord, Fatema Nader, Andrei Racila and Alita Mishra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and Gastroenterology.

In The Last Decade

Maria Stepanova

277 papers receiving 12.5k citations

Hit Papers

The economic and clinical... 2011 2026 2016 2021 2016 2011 2018 2011 2012 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
    2016 916 citations Zobair M. Younossi, Linda Henry et al. profile →
  2. Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
    2011 863 citations Zobair M. Younossi, Maria Stepanova et al. Clinical Gastroenterology and Hepatology profile →
  3. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
    2018 603 citations Zobair M. Younossi, Maria Stepanova et al. Clinical Gastroenterology and Hepatology profile →
  4. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
    2011 461 citations Zobair M. Younossi, Maria Stepanova et al. profile →
  5. Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
    2012 431 citations Zobair M. Younossi, Maria Stepanova et al. profile →
  6. Epidemiology of chronic liver diseases in the USA in the past three decades
    2019 387 citations Zobair M. Younossi, Maria Stepanova et al. Gut profile →
  7. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
    2020 373 citations Zobair M. Younossi, Maria Stepanova et al. Clinical Gastroenterology and Hepatology profile →
  8. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
    2024 156 citations Zobair M. Younossi, James M. Paik et al. Journal of Hepatology profile →
  9. The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease
    2023 71 citations Zobair M. Younossi, Maria Stepanova et al. Hepatology Communications profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Maria Stepanova 10.5k 7.2k 3.1k 1.6k 1.4k 295 12.7k
Robert J. Wong 6.1k 0.6× 4.8k 0.7× 1.5k 0.5× 2.2k 1.4× 1.2k 0.8× 323 10.4k
Rocío López 8.6k 0.8× 4.0k 0.6× 2.7k 0.9× 6.5k 4.2× 1.5k 1.1× 570 18.0k
Frank Lammert 6.6k 0.6× 5.3k 0.7× 1.0k 0.3× 5.4k 3.4× 1.0k 0.7× 514 15.3k
Kevin D. Mullen 7.4k 0.7× 7.1k 1.0× 907 0.3× 2.9k 1.8× 546 0.4× 171 10.3k
Peter Hayes 7.8k 0.7× 9.1k 1.3× 1.0k 0.3× 5.2k 3.3× 750 0.5× 431 14.4k
Mauro Bernardi 12.4k 1.2× 14.4k 2.0× 913 0.3× 5.9k 3.7× 1.3k 0.9× 346 19.6k
Péter Ferenci 9.3k 0.9× 9.7k 1.4× 543 0.2× 2.5k 1.6× 583 0.4× 393 17.4k
Wladimiro Jiménez 8.5k 0.8× 10.8k 1.5× 885 0.3× 5.8k 3.7× 483 0.3× 307 15.9k
Patrizia Burra 6.3k 0.6× 8.1k 1.1× 498 0.2× 4.3k 2.7× 1.1k 0.8× 477 12.7k
Frederik Nevens 7.8k 0.7× 9.2k 1.3× 411 0.1× 5.6k 3.5× 829 0.6× 435 15.4k

Countries citing papers authored by Maria Stepanova

Since Specialization
Citations

This map shows the geographic impact of Maria Stepanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Stepanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Stepanova more than expected).

Fields of papers citing papers by Maria Stepanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Stepanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Stepanova. The network helps show where Maria Stepanova may publish in the future.

Co-authorship network of co-authors of Maria Stepanova

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Stepanova. A scholar is included among the top collaborators of Maria Stepanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Stepanova. Maria Stepanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stepanova, Maria, А. В. Добродумов, И. В. Гофман, et al.. (2024). Chemical Modification of Nanocrystalline Cellulose for Manufacturing of Osteoconductive Composite Materials. Polymers. 16(13). 1936–1936. 4 indexed citations
2.
Younossi, Zobair M., James M. Paik, Maria Stepanova, et al.. (2024). Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. Journal of Hepatology. 80(5). 694–701. 156 indexed citations breakdown →
3.
Alqahtani, Saleh A., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2024). Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt. Journal of Viral Hepatitis. 31(6). 300–308. 4 indexed citations
4.
Alqahtani, Saleh A., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2024). Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region. Annals of Hepatology. 30(1). 101569–101569. 6 indexed citations
5.
Younossi, Zobair M., Maria Stepanova, Issah Younossi, & Andrei Racila. (2024). Validation of a Primary Biliary Cholangitis–Specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBC. Clinical and Translational Gastroenterology. 15(9). e1–e1. 5 indexed citations
6.
Stepanova, Maria, et al.. (2023). Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery. Pharmaceutics. 15(11). 2641–2641. 15 indexed citations
7.
Stepanova, Maria, Linda Henry, & Zobair M. Younossi. (2023). Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease. 27(2). 483–513. 24 indexed citations
8.
9.
Younossi, Zobair M., Maria Stepanova, Reem Q. Al Shabeeb, et al.. (2023). The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease. Hepatology Communications. 8(1). 71 indexed citations breakdown →
10.
Stepanova, Maria, И. В. Гофман, Н. Н. Шевченко, et al.. (2023). Drug Loaded 3D-Printed Poly(ε-Caprolactone) Scaffolds for Local Antibacterial or Anti-Inflammatory Treatment in Bone Regeneration. Polymers. 15(19). 3957–3957. 10 indexed citations
11.
Lam, Brian, Maria Stepanova, Chapy Venkatesan, et al.. (2022). Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system. PLoS ONE. 17(2). e0263417–e0263417. 5 indexed citations
12.
Younossi, Zobair M., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2022). The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry. Hepatology Communications. 6(10). 2860–2866. 3 indexed citations
13.
Younossi, Zobair M., Maria Stepanova, Fatema Nader, et al.. (2021). Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis. Clinical Gastroenterology and Hepatology. 20(9). 2050–2058.e12. 77 indexed citations
14.
Younossi, Zobair M., Vincent Wai‐Sun Wong, Quentin M. Anstee, et al.. (2020). Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes. Hepatology Communications. 4(11). 1637–1650. 42 indexed citations
15.
Younossi, Zobair M., Maria Stepanova, Youssef Younossi, et al.. (2019). Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 69(3). 564–568. 387 indexed citations breakdown →
16.
Stepanova, Maria, et al.. (2018). Clinical effectiveness of nutrof total supplement for Dry age-related macular Degeneration. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Younossi, Zobair M., Maria Stepanova, Tarik Asselah, et al.. (2017). Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. Clinical Infectious Diseases. 66(11). 1742–1750. 18 indexed citations
18.
Younossi, Zobair M., Maria Stepanova, Linda Henry, et al.. (2016). Association of work productivity with clinical and patient‐reported factors in patients infected with hepatitis C virus. Journal of Viral Hepatitis. 23(8). 623–630. 30 indexed citations
19.
Younossi, Zobair M., Maria Stepanova, Stanislas Pol, et al.. (2015). The impact of ledipasvir/sofosbuvir on patient‐reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study. Liver International. 36(1). 42–48. 45 indexed citations
20.
Younossi, Zobair M., Maria Stepanova, Fatema Nader, Brian Lam, & Sharon Hunt. (2015). The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon‐ and ribavirin‐free regimens: a study of health‐related quality of life. Alimentary Pharmacology & Therapeutics. 42(3). 286–295. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert J. Wong Breakdown of academic impact, for papers by Rocío López Breakdown of academic impact, for papers by Frank Lammert Breakdown of academic impact, for papers by Kevin D. Mullen Breakdown of academic impact, for papers by Peter Hayes Breakdown of academic impact, for papers by Mauro Bernardi Breakdown of academic impact, for papers by Péter Ferenci Breakdown of academic impact, for papers by Wladimiro Jiménez Breakdown of academic impact, for papers by Patrizia Burra Breakdown of academic impact, for papers by Frederik Nevens
Rankless by CCL
2026